High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study

• Published in: Clinical Infectious Diseases
• Main Authors: Johannesson, Jon M, Fridriksdottir, Ragnheidur H, Löve, Thorvardur J, Runarsdottir, Valgerdur, Hansdóttir, Ingunn, Löve, Arthur, Thordardottir, Marianna, Hernandez, Ubaldo B, Olafsson, Sigurdur, Gottfredsson, Magnus
• Format: Text
• Language: English
• Published: Oxford University Press 2022
• Subjects: Major Article; Random Point; Iceland
• Online Access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662175/; http://www.ncbi.nlm.nih.gov/pubmed/35438144; https://doi.org/10.1093/cid/ciac272

BACKGROUND: The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elimination efforts. We determined reinfection rates...